检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
机构地区:[1]兰州军区乌鲁木齐总医院中西医结合科,新疆乌鲁木齐830000
出 处:《中国中医药信息杂志》2015年第7期25-27,共3页Chinese Journal of Information on Traditional Chinese Medicine
摘 要:目的观察洗髓换骨方配合锝[99Tc]亚甲基二膦酸盐注射液治疗缺血性股骨头坏死(ANFH)的临床效果。方法将73例ANFH患者随机分为治疗组37例和对照组36例,对照组采用西医常规治疗,治疗组在对照组治疗基础上服用洗髓换骨方,观察2组患者治疗前后临床症状、髋关节功能情况,比较2组临床疗效。结果治疗组临床治愈17例,好转17例,未愈3例,有效率为91.89%;对照组临床治愈4例,好转25例,未愈7例,有效率为80.56%。2组临床疗效比较差异有统计学意义(P<0.05)。治疗组关节疼痛、跛行、功能障碍、关节功能改善情况均优于对照组(P<0.05)。结论洗髓换骨方能显著改善ANFH临床症状,中西医结合治疗有助于缓解ANFH疾病进展。Objective To observe the clinical effect of Xisui Huangu Formula combined with technetium [99Tc] methylenediphosphonate injection in the treatment of avascular necrosis of femoral head (ANFH). Methods A total of 73 patients were randomly divided into treatment group (37 cases) and control group (36 cases). The control group was given conventional western medicine treatment, while the treatment group was given Xisui Huangu Formula on the basis of conventional western medicine treatment. Clinical symptoms and joint function of the two groups were observed before and after treatment, and the clinical effects were compared. Results In the treatment group, 17 cases were cured, 17 cases improved, 3 cases were unrecovered, and the effective rate was 91.89%. In the control group, 4 cases were cured, 25 cases improved, 7 cases were unrecovered, and the effective rate was 80.56%. The difference was statistically significant between the two groups (P&lt;0.05). Improvement of joint pain, lameness, dysfunction, and joint function in the treatment group were better than those in the control group (P&lt;0.05). Conclusion Xisui Huangu Formula can significantly improve clinical symptoms of ANFH. Integrated traditional Chinese and Western medicine therapy is helpful to alleviate ANFH disease progression.
分 类 号:R274.917[医药卫生—中西医结合]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.118